These training sessions and other publicity programs have engendered sufficient interest among faculty and students on the use of grid computing technology, however, the low bandwidth challenges being experienced by the University as well as non linkage to existing grids has limited the use of the technology by faculty and students.
King submitted to the FDA its publicity plans, which for now include its AtroPen.com Web site, medical journal ads and training brochure, in August 2004 and is still waiting to hear from the government.